Effects of Ruxolitinib on fibrosis in preclinical models of systemic sclerosis
Nessrine Bellamri(Inserm), Valérie Lecureur(Inserm)
Cited by 26
Related Papers
Alteration of human macrophage phenotypes by the anti-fibrotic drug nintedanib
|International Immunopharmacology|2019|63
Distinct Properties of Human M-CSF and GM-CSF Monocyte-Derived Macrophages to Simulate Pathological Lung Conditions In Vitro: Application to Systemic and Inflammatory Disorders with Pulmonary Involvement
|International Journal of Molecular Sciences|2018|52
Le macrophage dans la fibrose pulmonaire idiopathique : effets du nintédanib et expression du biomarqueur pronostique CXCL13
|ORI-OAI warehouse (University of Rennes)|2019|0